Comparison of Two Regimens of Anesthesia for Children Undergoing Magnetic Resonance Imaging (MRI) in General Anesthesia

Comparison of two regimens (Sevorane/LMA ctr. Propofol/Remifentanil) for children undergoing MRI in general anesthesia.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

General Anesthesia Children MRI Propofol/Remifentanil Sevoflurane

Age range

1 year–10 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Glostrup University Hospital, Dept. of Anesthesia

Glostrup Municipality, Copenhagen, DK-2600, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

children aged 1 to 10 yrs.
ASA 1-2

Exclusion criteria

Allergy to soya (propofol)
Allergy to Pentobarbital
Allergy to Remifentanil
Allergy to Sevoflurane
Children undergoing blood tests or further examinations in conjunction with the MRI
Children with unexplained fever
Children which are evaluated not to be able to keep a open airway

Treatment and study plan

Primary outcomes

postanaesthetic recovery and behavioral score

Time frame: 0-24 hours hours postoperatively

Secondary outcomes

Time span of the recovery process

Time frame: 0-3 hours postoperatively

Sponsors and collaborators

Lead sponsor

Niels Anker Pedersen

Other

Registry information

Official study title

Comparison of Two Regimens of Anesthesia for Children Undergoing MRI in General Anesthesia. Advantages, Disadvantages and Time Consumption Regarding the Two Regimens.

Important dates

Study start: 2008
Primary completion: 2011
Study completion: 2011
First posted: Jul 30, 2009
Registry last updated: May 27, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed